FOX
59
2
KO
42
-2
HRL
39
9
HSIC
42
-3
BF.B
32
3
ZBH
62
-3
IPG
44
-3
COP
59
2
QRVO
6
2
TDC
73
2
OXY
52
-3
AMAT
46
3
DGX
39
-9
ECL
59
-3
NUE
53
-5
ADSK
70
-4
MUR
48
3
FRT
45
-3
XRAY
23
3
BMY
63
2
FOX
59
2
KO
42
-2
HRL
39
9
HSIC
42
-3
BF.B
32
3
ZBH
62
-3
IPG
44
-3
COP
59
2
QRVO
6
2
TDC
73
2
OXY
52
-3
AMAT
46
3
DGX
39
-9
ECL
59
-3
NUE
53
-5
ADSK
70
-4
MUR
48
3
FRT
45
-3
XRAY
23
3
BMY
63
2
Financhill
Back

SpringWorks Therapeutics 10K Form

Buy
64

SWTX
SpringWorks Therapeutics

Last Price:
35.47
Seasonality Move:
54.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SWTX News And Ratings

See the #1 stock for the next 7 days that we like better than SWTX

SWTX Financial Statistics

Sales & Book Value

Annual Sales: $5.45M
Cash Flow: $-54.02M
Price / Cash Flow: 0
Annual Sales: $7.50
Price / Book: 4.88

Profitability

EPS (TTM): -4.44000
Net Income (TTM): $-301.06M
Gross Margin: $5.03M
Return on Equity: -57.97%
Return on Assets: -50.43%

SpringWorks Therapeutics Earnings Forecast

Key SpringWorks Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 3 years for SWTX is 92.25%.
  • The Selling, General & Administrative Expenses for SWTX have been equal to 3,626.79% of Gross Profit Margin.
  • The Research & Development expenses have been 2,762.75% of Revenue.
  • The Net Earning history of SWTX is -5,968.50% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

SpringWorks Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SWTX
CUSIP: 85205L
Website: springworkstx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.91
Quick Ratio: 7.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SWTX Technical Analysis vs Fundamental Analysis

Buy
64
SpringWorks Therapeutics (SWTX) is a Buy

Is SpringWorks Therapeutics a Buy or a Sell?